Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04928326 · ClinicalTrials.gov registry record

Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure

A clinical trial of Heart Failure, sponsored by InCardia.

Completed
Registry status
43
Enrollment target
1
Study location

NCT04928326: Completed study of Heart Failure, sponsored by InCardia.

NCT04928326 is a study of Heart Failure that has completed, run by InCardia. The registered enrollment target is 43 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04928326, a study of Heart Failure, has completed, sponsored by InCardia.

COMPLETED
Registry status
43 participants
Enrollment target
1
Study location

Study Summary

This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a cardiac catheterization laboratory (cath lab) and in a cardiac intensive care unit (ICU).

Primary Outcome

Agreement between the CVP/RAP as assessed by the CorWatchTM method and the right arterial pressure (RAP) as measured by SG catheter

Conditions Studied

Heart Failure

Interventions

  • DIAGNOSTIC_TEST CorWatch

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2021-08-01
Est. Completion 2022-10-01
InCardia

1 total trials

What the finished NCT04928326 record still lists

NCT04928326 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CorWatch is the first listed.

NCT04928326 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04928326 about?

NCT04928326 is a clinical study titled "Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure". This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a ca...

What is the current status of trial NCT04928326?

This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-08-01. Estimated completion is 2022-10-01.

What conditions does trial NCT04928326 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT04928326?

The interventions under investigation include: CorWatch (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04928326?

This trial is sponsored by InCardia, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04928326 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04928326's enrollment target sits among peer trials

43 299th of 397 higher than 97 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04928326, the US trial registry maintained by the National Library of Medicine. NCT04928326 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.